Literature DB >> 9241071

Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking.

S D Stellman1, J E Muscat, S Thompson, D Hoffmann, E L Wynder.   

Abstract

BACKGROUND: Over the past few decades, the incidence of adenocarcinoma (AC) of the lung increased much more rapidly than that of squamous cell carcinoma (SCC) in men and women. During this time period, filter cigarettes with substantially reduced "tar" and nicotine yields in the smoke came to dominate the market.
METHODS: The risk of SCC and AC in lifelong smokers of filter cigarettes relative to lifelong nonfilter cigarette smokers was assessed in a case-control study performed between 1977 and 1995 with 2292 lung carcinoma patients and 1343 hospital controls who were current smokers.
RESULTS: Odds ratios (OR) for SCC in male and female subjects who had smoked filter cigarettes exclusively during their lives were slightly reduced relative to lifetime nonfilter cigarette smokers in men (OR = 0.8; 95% confidence interval [CI], 0.5-1.2), and significantly reduced in women (OR = 0.4; 95% CI, 0.2-0.8). No reduction in risk was observed for AC of the lung in men or women.
CONCLUSIONS: Evidence that the increasing predominance of AC over SCC may be due in part to the reduced risk of SCC (but not AC) associated with lifelong filter cigarette smoking is strongest in women; for men, further studies that include larger numbers of lifetime filter smokers are needed to confirm this finding. A lack of protection against AC from low yield filter cigarettes may result from smokers' "compensating" with deeper and more frequent inhalation, thereby increasing delivery of carcinogens to the peripheral lung. The smoke of modern cigarettes also contains higher concentrations of nitrosamines that primarily produce AC.

Entities:  

Mesh:

Year:  1997        PMID: 9241071     DOI: 10.1002/(sici)1097-0142(19970801)80:3<382::aid-cncr5>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  37 in total

1.  Mentholated cigarettes and smoking habits in whites and blacks.

Authors:  J E Muscat; J P Richie; S D Stellman
Journal:  Tob Control       Date:  2002-12       Impact factor: 7.552

Review 2.  Pollutional haze as a potential cause of lung cancer.

Authors:  Xuefei Shi; Hongbing Liu; Yong Song
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

3.  The consequences of the unregulated cigarette.

Authors:  Nigel Gray
Journal:  Tob Control       Date:  2006-10       Impact factor: 7.552

4.  A case-control study of smoking and bladder cancer risk: emergent patterns over time.

Authors:  Dalsu Baris; Margaret R Karagas; Castine Verrill; Alison Johnson; Angeline S Andrew; Carmen J Marsit; Molly Schwenn; Joanne S Colt; Sai Cherala; Claudine Samanic; Richard Waddell; Kenneth P Cantor; Alan Schned; Nathaniel Rothman; Jay Lubin; Joseph F Fraumeni; Robert N Hoover; Karl T Kelsey; Debra T Silverman
Journal:  J Natl Cancer Inst       Date:  2009-11-16       Impact factor: 13.506

5.  Disentangling tobacco-related lung cancer-genome-wide interaction study of smoking behavior and non-small cell lung cancer risk.

Authors:  María Lorenzo-González; Alberto Fernández-Villar; Alberto Ruano-Ravina
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

Review 6.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

7.  Health impact of "reduced yield" cigarettes: a critical assessment of the epidemiological evidence.

Authors:  M J Thun; D M Burns
Journal:  Tob Control       Date:  2001       Impact factor: 7.552

Review 8.  Epidemiology of lung cancer.

Authors:  Carole A Ridge; Aoife M McErlean; Michelle S Ginsberg
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

9.  Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009.

Authors:  Keisha A Houston; S Jane Henley; Jun Li; Mary C White; Thomas B Richards
Journal:  Lung Cancer       Date:  2014-08-12       Impact factor: 5.705

10.  Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways.

Authors:  Alain C Borczuk; Lyall Gorenstein; Kristin L Walter; Adel A Assaad; Liqun Wang; Charles A Powell
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.